Tempest Therapeutics, Inc. Common Stock (NASDAQ: TPST) last traded at $0.701, down 5.64% on the session. The quote above updates while this page is open; the figures below are drawn from Tempest Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Tempest Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TPST. Its market capitalisation is $10.38 million.
Valuation measures for Tempest Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $10.38M |
|---|---|
| Enterprise value | $20.32M |
| Beta | 0.59 |
Trailing-twelve-month figures tagged in Tempest Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$40.47M |
|---|---|
| Cash |
|---|
| $779.0K |
Range and volume for TPST over the past 52 weeks.
| 52-week high | $12.23 |
|---|---|
| 52-week low | $0.691 |
| Volume | 170.5K |
| Average volume | 2.52M |
| Previous close | $0.743 |
Invest a chosen dollar amount in Tempest Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TPST.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.